Comparison between 8-prenylnarigenin and narigenin concerning their activities on promotion of rat bone marrow stromal cells' osteogenic differentiation in vitro

Cell Proliferation

Volumn 45, Issue 6, 2012, Pages 508-515

  Ming, L G ^a   Ge, B F ^a   Wang, M G ^b   Chen, K M ^a  

^a LANZHOU GENERAL HOSPITAL   (China)

^b LANZHOU UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

8 PRENYLNARIGENIN; ALKALINE PHOSPHATASE; BONE MORPHOGENETIC PROTEIN 2; CALCIUM; FLAVONOL DERIVATIVE; MITOGEN ACTIVATED PROTEIN KINASE P38; NARIGENIN; NATURAL PRODUCT; OSTEOPROTEGERIN; TRANSCRIPTION FACTOR OSTERIX; TRANSCRIPTION FACTOR RUNX2; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; BONE DEVELOPMENT; BONE MARROW CELL; BONE MARROW STROMAL CELL; BONE MINERALIZATION; CELL DIFFERENTIATION; CONTROLLED STUDY; ENZYME ACTIVITY; GENE EXPRESSION; HISTOCHEMISTRY; IN VITRO STUDY; MALE; NONHUMAN; NUCLEOTIDE SEQUENCE; OSTEOBLAST; PROTEIN EXPRESSION; RAT; REAL TIME POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; STROMA CELL; WESTERN BLOTTING;

ALKALINE PHOSPHATASE; ANIMALS; CELL DIFFERENTIATION; CELLS, CULTURED; ESTROGEN ANTAGONISTS; FLAVANONES; GENE EXPRESSION REGULATION, DEVELOPMENTAL; MALE; MESENCHYMAL STROMAL CELLS; OSTEOBLASTS; OSTEOCALCIN; OSTEOGENESIS; PHYTOESTROGENS; RATS; RATS, WISTAR; SIGNAL TRANSDUCTION;

RATTUS;

EID: 84868097323     PISSN: 09607722     EISSN: 13652184     Source Type: Journal    
DOI: 10.1111/j.1365-2184.2012.00844.x     Document Type: Article

References (27)

1. Mundy GR (1996) Regulation of bone formation by bone morphogenetic proteins and other growth factors. Clin. Orthop. 324, 24-28.
2. Jia TL, Wang HZ, Xie LP, Wang XY, Zhang RQ (2003) Daidzein enhance osteoblast growth that may be mediated by increased bone morphogenetic protein (BMP) production. Biochem. Pharmacol. 65, 709-715.
3. Michitaka N, Eri O, Akira Y, Hiromi H (2004) Runx-2 is not essential for the vitamin D-regulated expression of RANKL and osteoprotegerin in osteoblastic cells. J. BBRC 324, 655-660.
4. Ulsamer A, Ortuon MJ, Ruiz S (2008) BMP-2 induces Osterix expression through up-regulation of Dlx5 and its phosphorylation by p38. J. Biol. Chem. 238, 3816-3826.
5. Liu T, Gao Y, Sakamoto K (2007) BMP-2 promotes differentiation of osteoblasts and chondroblasts in Runx2-deficient cell lines. J. Cell. Physiol. 211, 728-735.
6. Nohe A, Keating E, Knaus P (2004) Signal transduction of bone morphogenetic protein receptors. J. Cell Signal. 16, 291-299.
7. Jeon EJ, Lee KY, Choi NS (2006) Bone morphogenetic protein-2 stimulates Runx2 acetylation. J. Biol. Chem. 281, 16502-16511.
8. Ichida F, Nishimura R, Hata K, Matsubara T, Ikeda F, Hisada K, et al. (2004) Reciprocal roles of Msx2 in regulation of osteoblast and adipocyte differentiation. J. Biol. Chem. 279, 34015-34022.
9. Kong AN, Yu R, Chen C, Mandlekar S, Primiano T (2000) Signal transduction events elicited by natural products: role of MAPK and caspase pathways in homeostatic response and induction of apoptosis. Arch. Pharm. Res. 23, 1-16.
10. Seger R, Krebs EG (1995) The MAPK signaling cascade. FASEB J. 9, 726-735.
11. Ming LG, Zhou J, Cheng GZ, Ma HP, Chen KM (2011) Osthol, a coumarin isolated from common cnidium fruit, enhances the differentiation and maturation of osteoblasts in vitro. Pharmacology 88, 33-43.
12. Sugimoto E, Yamaguchi M (2000) Stimulatory effect of daidzein in osteoblastic MC3T3-E3 cells. Biochem. Pharmacol. 59, 471-475.
13. Sugimoto E, Yamaguchi M (2000) Anabolic effect of genistein in osteoblastic MC3T3-E3 cells. Int. J. Mol. Med. 5, 515-520.
14. Ma HP, Ming LG, Ge BF et al. (2011) Icariin is more potent than genistein in promoting osteoblast differentiation and mineralization in vitro. J. Cell. Biochem. 112, 916-923.
15. Sehmisch S, Hammer F, Christoffel J, Seidlova-Wuttke D, Tezval M, Wuttke W, et al. (2008) Comparison of the phytohormones genistein, resveratrol and 8-prenylnaringenin as agents for preventing osteoporosis. Planta Med. 74, 794-801.
16. Hsieh TP, Sheu SY, Sun JS, Chen MH, Liu MH. (2010) Icariin isolated from Epimedium pubescens regulates osteoblasts anabolism through BMP-2, SMAD4, and Cbfa1 expression. Phytomedicine 17, 414-423.
17. Hsieh TP, Sheu SY, Sun JS, Chen MH. (2011) Icariin inhibits osteoclast differentiation and bone resorption by suppression of MAPKs/NF-kappaB regulated HIF-1alpha and PGE(2) synthesis. Phytomedicine 18, 176-185.
18. Wada Y, Kataoka H, Yokose S, Ishizuya T, Miyazono K, Gao YH et al. (1998) Changes in osteoblast phenotype during differentiation of enzymatically isolated rat calvaria cells. Bone 22, 479-485.
19. Zhang Y, Li XL, Yao XS, Wong MS. (2008) Osteogenic activities of genistein derivatives were influenced by the presence of prenyl group at ring A. Arch. Pharm. Res. 31, 1534-1539.
20. Ming LG, Chen KM, Ge BF, Ma HP, Zhai YK (2011) Investigated the effect of 8-Prenylnaringenin on bone marrow stromal cells differentiation in vitro. Chin. Pharmacol. Bull. 27, 421-427.
21. Ming LG, Chen KM, Ge BF, Ma HP, Zhai YK (2010) Effects of 8-Prenylnaringenin on osteoblasts differentiate and biomineralization in vitro. Progr. Biochem. Biophys. 38, 1-8.
22. Nian H, Ma MH, Nian SS, Xu LL (2009) Antiosteoporotic activity of icariin in ovariectomized rats. Phytomedicine 16, 320-326.
23. Hamamura K, Goldring MB, Yokota H (2009) Involvement of p38 MAPK in regulation of MMP13 mRNA in chondrocytes in response to surviving stress to endoplasmic reticulum. Arch. Oral Biol. 54, 279-286.
24. Pantouli E, Boehm MM, Koka S (2005) Inflammatory cytokines activate p38MAPK to induce osteoprotegerin synthesis by MG-63 cells. Biochem. Biophys. Res. Commun. 329, 224-229.
25. Zhao J, Ohba S, Shinkai M, Chung UI et al. (2008) Icariin induces osteogenic differentiation in vitro in a BMP- and Runx2-dependent manner. Biochem. Biophys. Res. Commun. 369, 444-448.
26. Hsieh T, Sheu S, Sun J, Chen M (2011) Icariin inhibits osteoclast differentiation and bone resorption by suppression of MAPKs/NF-[kappa]B regulated HIF-1[alpha] and PGE2 synthesis. Phytomedicine 18, 176-185.
27. Mok SK, Chen WF, Lai WP, Leung PC, Wang XL, Yao XS, Wong MS (2010) Icariin protects against bone loss induced by oestrogen deficiency and activates oestrogen receptor-dependent osteoblastic functions in UMR 106 cells. Br. J. Pharmacol. 159, 939-949.